BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Hadasit Bio-Holdings Ltd. Portfolio Company Cell Cure Neurosciences Ltd. Receives Additional Financing From BioTime

  November 12, 2012

   · 

  6 min read
• Drug Development

  PATH’s Drug Development Program Announces Positive Phase 1 Results for Its Anti-Diarrheal Medication

  November 12, 2012

   · 

  1 min read
• Drug Development

  Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases

  November 12, 2012

   · 

  1 min read
• Genetown

  American Association for Study of Liver Diseases Curriculum & Training (ACT) Launches With New Interactive HCV Education

  November 12, 2012

   · 

  5 min read
• Drug Development

  Nektar Therapeutics (CA) to Host Conference Call to Discuss The Positive Phase 3 Clinical Results for Naloxegol

  November 12, 2012

   · 

  3 min read
• BioMidwest

  Michigan Biosciences Organization - MichBio Expo Brought the Who’s Who in Michigan Biotech

  November 12, 2012

   · 

  1 min read
• Business

  Cell Therapeutics, Inc. Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations

  November 12, 2012

   · 

  2 min read
• Drug Development

  3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012

  November 12, 2012

   · 

  3 min read
• Drug Development

  AEterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer

  November 12, 2012

   · 

  5 min read
• Drug Development

  Janssen Research & Development Release: New Phase 3 Findings Show STELARA® Significantly Reduced Signs and Symptoms of Active Psoriatic Arthritis

  November 12, 2012

   · 

  16 min read